Immucell (ICCC) Assets (QoQ) (2011 - 2025)
Immucell (ICCC) Assets (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Immucell | 93.37 Mn | 84.51 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.99% |
| Sep 30, 2025 | -2.12% |
| Jun 30, 2025 | 2.41% |
| Mar 31, 2025 | 1.16% |
| Dec 31, 2024 | 1.47% |
| Sep 30, 2024 | 6.20% |
| Jun 30, 2024 | -2.78% |
| Mar 31, 2024 | -1.73% |
| Dec 31, 2023 | -1.65% |
| Sep 30, 2023 | 1.22% |
| Jun 30, 2023 | 2.05% |
| Mar 31, 2023 | -3.87% |
| Dec 31, 2022 | -3.32% |
| Sep 30, 2022 | 0.91% |
| Jun 30, 2022 | -1.53% |
| Mar 31, 2022 | 5.02% |
| Dec 31, 2021 | 0.53% |
| Sep 30, 2021 | 1.15% |
| Jun 30, 2021 | 10.37% |
| Mar 31, 2021 | -1.80% |